Advertisement
Regular article Cardiovascular, pulmonary, and renal pathology| Volume 179, ISSUE 1, P167-179, July 2011

Plexiform Lesions in Pulmonary Arterial Hypertension

Composition, Architecture, and Microenvironment
Open ArchivePublished:May 12, 2011DOI:https://doi.org/10.1016/j.ajpath.2011.03.040
      Pulmonary arterial hypertension (PAH) is a debilitating disease with a high mortality rate. A hallmark of PAH is plexiform lesions (PLs), complex vascular formations originating from remodeled pulmonary arteries. The development and significance of these lesions have been debated and are not yet fully understood. Some features of PLs resemble neoplastic disorders, and there is a striking resemblance to glomeruloid-like lesions (GLLs) in glioblastomas. To further elucidate PLs, we used in situ methods, such as (fluorescent) IHC staining, three-dimensional reconstruction, and laser microdissection, followed by mRNA expression analysis. We generated compartment-specific expression patterns in the lungs of 25 patients (11 with PAH associated with systemic shunts, 6 with idiopathic PAH, and 8 controls) and GLLs from 5 glioblastomas. PLs consisted of vascular channels lined by a continuously proliferating endothelium and backed by a uniform myogenic interstitium. They also showed up-regulation of remodeling-associated genes, such as HIF1a, TGF-β1, VEGF-α, VEGFR-1/-2, Ang-1, Tie-2, and THBS1, but also of cKIT and sprouting-associated markers, such as NOTCH and matrix metalloproteinases. The cellular composition and signaling seen in GLLs in neural neoplasms differed significantly from those in PLs. In conclusion, PLs show a distinct cellular composition and microenvironment, which contribute to the plexiform phenotype and set them apart from other processes of vascular remodeling in patients with PAH. Neoplastic models of angiogenesis seem to be of limited use in further study of plexiform vasculopathy.
      Pulmonary arterial hypertension (PAH) may occur either as a primary disease of unknown cause [idiopathic PAH (IPAH)] or as an associated manifestation of other diseases or malformations [eg, congenital shunts between the systemic and pulmonary circulation; associated PAH (APAH)].
      • Simonneau G.
      • Galie N.
      • Rubin L.J.
      • Langleben D.
      • Seeger W.
      • Domenighetti G.
      • Gibbs S.
      • Lebrec D.
      • Speich R.
      • Beghetti M.
      • Rich S.
      • Fishman A.
      Clinical classification of pulmonary hypertension.
      • Firth A.L.
      • Mandel J.
      • Yuan J.X.
      Idiopathic pulmonary arterial hypertension.
      Characteristic histologic findings of PAH include remodeling of small pulmonary arteries and arterioles with varying degrees of endothelial cell proliferation, muscular hypertrophy, and intimal fibrosis, ultimately leading to an obliteration of precapillary vessels. Morphologic hallmarks of severe PAH are the so-called plexiform lesions (PLs): complex, glomeruloid-like vascular structures originating from the pulmonary arteries.
      • Sakao S.
      • Tatsumi K.
      • Voelkel N.F.
      Endothelial cells and pulmonary arterial hypertension: apoptosis, proliferation, interaction and transdifferentiation.
      • Pietra G.G.
      • Edwards W.D.
      • Kay J.M.
      • Rich S.
      • Kernis J.
      • Schloo B.
      • Ayres S.M.
      • Bergofsky E.H.
      • Brundage B.H.
      • Detre K.M.
      Histopathology of primary pulmonary hypertension: a qualitative and quantitative study of pulmonary blood vessels from 58 patients in the National Heart, Lung, and Blood Institute, Primary Pulmonary Hypertension Registry.
      Whether PLs represent just a morphologic “indicator lesion” or play a role in the pathogenesis and/or progression of PAH has not yet been clarified. On a more basal level, even the actual cellular composition of PLs has not been conclusively determined: the high plasticity of the (mesenchymal) cells involved, ie, their ability to change their phenotype depending on the current local microenvironment, have hampered analysis.
      • Stevens T.
      Molecular and cellular determinants of lung endothelial cell heterogeneity.
      • Owens G.K.
      • Kumar M.S.
      • Wamhoff B.R.
      Molecular regulation of vascular smooth muscle cell differentiation in development and disease.
      The favored consensus describes the PL as a proliferating network of endothelial-lined vascular channels supported by a core of specialized and apoptosis-resistant myofibroblasts, smooth muscle cells, or even undifferentiated mesenchymal cells.
      • Cool C.D.
      • Stewart J.S.
      • Werahera P.
      • Miller G.J.
      • Williams R.L.
      • Voelkel N.F.
      • Tuder R.M.
      Three-dimensional reconstruction of pulmonary arteries in plexiform pulmonary hypertension using cell-specific markers: evidence for a dynamic and heterogeneous process of pulmonary endothelial cell growth.
      Animal models using chronic hypoxia combined with the application of SU5416 (semaxinib), a vascular endothelial growth factor receptor (VEGFR) blocker, have produced glomeruloid lesions that mimic the formation of PLs to a certain extent.
      • Abe K.
      • Toba M.
      • Alzoubi A.
      • Ito M.
      • Fagan K.A.
      • Cool C.D.
      • Voelkel N.F.
      • McMurtry I.F.
      • Oka M.
      Formation of plexiform lesions in experimental severe pulmonary arterial hypertension.
      These lesions develop early after treatment with SU5416 combined with hypoxia, a situation that does not fully mirror the situation in humans, where there is evidence that severe pulmonary arterial pressure over a longer period is needed to induce PLs.
      • Abe M.
      • Kimura T.
      • Morimoto T.
      • Taniguchi T.
      • Yamanaka F.
      • Nakao K.
      • Yagi N.
      • Kokubu N.
      • Kasahara Y.
      • Kataoka Y.
      • Otsuka Y.
      • Kawamura A.
      • Miyazaki S.
      • Horiuchi K.
      • Ito A.
      • Hoshizaki H.
      • Kawaguchi R.
      • Setoguchi M.
      • Inada T.
      • Kishi K.
      • Sakamoto H.
      • Morioka N.
      • Imai M.
      • Shiomi H.
      • Nonogi H.
      • Mitsudo K.
      Sirolimus-eluting stent versus balloon angioplasty for sirolimus-eluting stent restenosis: insights from the j-Cypher Registry.
      Moreover, neoangiogenesis in peritumoral tissue, such as the so-called glomeruloid-like lesions (GLLs) in high-grade neural tumors, have also been discussed as a putative model for PLs.
      • Tuder R.M.
      • Voelkel N.F.
      Plexiform lesion in severe pulmonary hypertension: association with glomeruloid lesion.
      • Skuli N.
      • Liu L.
      • Runge A.
      • Wang T.
      • Yuan L.
      • Patel S.
      • Iruela-Arispe L.
      • Simon M.C.
      • Keith B.
      Endothelial deletion of hypoxia-inducible factor-2α (HIF-2α) alters vascular function and tumor angiogenesis.
      • Sakao S.
      • Tatsumi K.
      The effects of antiangiogenic compound SU5416 in a rat model of pulmonary arterial hypertension.
      • Tuder R.M.
      • Groves B.
      • Badesch D.B.
      • Voelkel N.F.
      Exuberant endothelial cell growth and elements of inflammation are present in plexiform lesions of pulmonary hypertension.
      This experimental approach is compatible with the concept of the PL, or rather the adjacent artery from which it arises, as a circumscript angiogenic reservoir or niche that accommodates endothelial cells with a “quasi neoplastic” behavior, which contributes to remodeling of the pulmonary vasculature.
      • Rai P.R.
      • Cool C.D.
      • King J.A.
      • Stevens T.
      • Burns N.
      • Winn R.A.
      • Kasper M.
      • Voelkel N.F.
      The cancer paradigm of severe pulmonary arterial hypertension.
      Thus, although extensive analyses have been performed in animal experiments or alternative, tumor-associated vascular models that show a degree of morphologic similarity, actual PLs in humans have not yet been studied in more detail.
      In this work, we studied the cellular composition, architecture, and local signaling of PLs in human PAH lungs. We compared the microenvironment in PLs with that in tumor-associated GLLs to examine the relevance of neoplastic models as a research platform for PLs. Furthermore, we aimed to explore whether PLs represent an epiphenomenon in severe PAH and whether the “angiogenic niche” plays a major role in vascular remodeling.

      Materials and Methods

      Specimens

      We chose to focus on vascular remodeling in APAH associated with congenital heart disease. To this end, we selected 11 bilateral lung explants from patients with Eisenmenger's syndrome (New York Heart Association class IV). Of these patients, 7 showed prominent PLs (age at transplantation: arithmetic mean ± SD, 37.4 ± 9.9 years; median, 38 years) and 4 did not (age at transplantation: arithmetic mean ± SD, 34.5 ± 19.3 years; median, 28.8 years). Unagitated, nonremodeled pulmonary arteries taken from downsized lung tissue of donor lungs (n = 8) resected immediately before transplantation served as a reference for mRNA and protein expression analyses (Table 1).
      Table 1Characteristics of the 11 Study Patients and 8 Controls
      No.SexAPAH with PLsAPAH without PLsHeath-Edwards gradeControlsAge at Tx (years)Underlying conditionNYHA class at TxMean PAP at Tx (mmHg)
      1FX451Atrial septal defectIV65
      2MX442Atrial septal defectIV70
      3FX445Ventricular septal defectIV79
      4FX431Ventricular septal defectIV72
      5MX438Complex cardiac malformationIV65
      6FX434Patent ductus arteriosusIV62
      7FX421Univentricular heartIV68
      8MX323Complex cardiac malformationIV65
      9MX358Complex cardiac malformationIV68
      10FX342Complex cardiac malformationIV70
      11MX315Alström's syndromeIV80
      12FX66NANANA
      13FX56NANANA
      14FX46NANANA
      15FX42NANANA
      16MX49NANANA
      17MX43NANANA
      18MX43NANANA
      19MX20NANANA
      F, female; M, male; NA, not applicable; NYHA, New York Heart Association; PAP, pulmonary arterial pressure; Tx, treatment.
      In addition, we selected six bilateral lung explants from patients with IPAH (New York Heart Association class IV), all of them exhibiting prominent PLs (age at transplantation: arithmetic mean ± SD, 32.7 ± 17.1 years; median, 34 years). One of these patients carried a mutation of the BMP receptor 2 (BMPR2) (see Supplemental Table S1 at http://ajp.amjpathol.org).
      All the specimens were inflated with formalin by the main bronchi and were formalin-fixed overnight before being extensively sampled and paraffin-embedded (FFPE). Subsequently, they were histologically evaluated, graded according to the Heath-Edwards classification, and correlated with clinical data to confirm the (histopathologic) diagnosis.
      • Heath D.
      • Edwards J.E.
      The pathology of hypertensive pulmonary vascular disease: a description of six grades of structural changes in the pulmonary arteries with special reference to congenital cardiac septal defects.
      In addition, five high-grade glial neoplasms (glioblastomas multiforme) with prominent peritumoral neoangiogenesis forming so-called GLLs were examined. The FFPE samples were retrieved from the archives of the Institute of Pathology of Hannover Medical School and were handled anonymously, following the requirements of the local ethics committee.

      Light Microscopy and IHC Staining

      Serially cut slides were IHC stained for different markers of endothelial and smooth muscle differentiation, vascular remodeling, fibrosis, and inflammation-associated markers using monoclonal antibodies and following a standard ABC protocol [angiopoietin (Ang)-1, Ang-2, CD3, CD20, CD31, CD34, CD68 (KP1), CD117 (c-KIT), CD141 (thrombomodulin), desmin Ki-67, mast cell tryptase, myocardin, β-type platelet-derived growth factor receptor, podoplanin, SMA, smooth muscle myosin heavy chain (smmhc), transforming growth factor (TGF)-β1, thrombospondin (THBS)-1, and VEGF-α; Table 2]. The staining intensity in different compartments was assessed in at least two locations in both lobes of the lung specimens as no reactivity, barely visible reactivity at high magnification (“weak”), well-recognizable reactivity at medium magnification (“intermediate”), and high protein expression levels visible even at low magnification (“strong”).
      • Ruschoff J.
      • Dietel M.
      • Baretton G.
      • Arbogast S.
      • Walch A.
      • Monges G.
      • Chenard M.P.
      • Penault-Llorca F.
      • Nagelmeier I.
      • Schlake W.
      • Hofler H.
      • Kreipe H.H.
      HER2 diagnostics in gastric cancer-guideline validation and development of standardized immunohistochemical testing.
      The range of positive cells in the different compartments was scored semiquantitatively as no apparent reaction (score 0), positivity in <30% (score 1), positivity in ≥30% and <60% (score 2), and positivity in ≥60% (score 3) of cells.
      • Jonigk D.
      • Merk M.
      • Hussein K.
      • Maegel L.
      • Theophile K.
      • Muth M.
      • Lehmann U.
      • Bockmeyer C.L.
      • Mengel M.
      • Gottlieb J.
      • Welte T.
      • Haverich A.
      • Golpon H.
      • Kreipe H.
      • Laenger F.
      Obliterative airway remodeling molecular evidence for shared pathways in transplanted and native lungs.
      • Jonigk D.
      • Theophile K.
      • Hussein K.
      • Bock O.
      • Lehmann U.
      • Bockmeyer C.L.
      • Gottlieb J.
      • Fischer S.
      • Simon A.
      • Welte T.
      • Maegel L.
      • Kreipe H.
      • Laenger F.
      Obliterative airway remodelling in transplanted and non-transplanted lungs.
      Table 2Antibodies Used in the Study
      ProteinCompanyDilution
      Ang-1R&D Systems, Minneapolis, MN1:15
      Ang-2R&D Systems1:50
      CD3Dako, Carpinteria, CA1:200
      CD20Dako1:50
      CD31Dako1:75
      CD34Leica Microsystems GmbH, Wetzlar, GermanyReady to use
      CD68 (KP1)Dako1:100
      CD117 (c-KIT)Zytomed Systems GmbH, Berlin, Germany1:50
      CD141 (thrombomodulin)AbD Serotec, Raleigh, NC1:20
      DesminDako1:75
      Ki-67Thermo Fisher Scientific, Waltham, MA1:100
      Mast cell tryptaseLeica Microsystems GmbH1:50
      MyocardinCovalab S.A.S., Villeurbanne France1:200
      β-Type platelet-derived growth factor receptorAcris Antibodies Inc., San Diego, CA1:50
      PodoplaninAcris Antibodies Inc.1:25
      SMADako1:25
      SmmhcUS Biological, Swampscott, MA1:100
      TGF-β1Acris Antibodies Inc.1:500
      THBS1Lifespan, Providence, RI1:20
      VEGF-αSanta Cruz Biotechnology, Santa Cruz, CA1:50
      The detection system was the DAB Zytomed HRP kit (Zytomed Systems GmbH) for all.
      We examined PLs and the adjacent arteries from which they sprout: remodeled arteries ≤750 μm from the corresponding PL, with varying degrees of media hypertrophy and (concentric) intimal proliferation. In PAH lungs without PLs, we analyzed remodeled arteries, which showed concentric laminar intimal proliferation and fibrosis (“concentric lesions” with a diameter of ≤500 μm). Unagitated arterial vessels from downsized lung tissue of donor lungs served as controls.
      Inflammatory cells in PLs and their adjacent vessels and in controls were quantitated by counting the number of positively marked cells per square millimeter (positivity for CD3, CD20, CD45, CD68, and mast cell tryptase; Table 2). Staining intensity, where applicable, was graded as weak, intermediate, or strong.
      • Jonigk D.
      • Merk M.
      • Hussein K.
      • Maegel L.
      • Theophile K.
      • Muth M.
      • Lehmann U.
      • Bockmeyer C.L.
      • Mengel M.
      • Gottlieb J.
      • Welte T.
      • Haverich A.
      • Golpon H.
      • Kreipe H.
      • Laenger F.
      Obliterative airway remodeling molecular evidence for shared pathways in transplanted and native lungs.
      • Jonigk D.
      • Theophile K.
      • Hussein K.
      • Bock O.
      • Lehmann U.
      • Bockmeyer C.L.
      • Gottlieb J.
      • Fischer S.
      • Simon A.
      • Welte T.
      • Maegel L.
      • Kreipe H.
      • Laenger F.
      Obliterative airway remodelling in transplanted and non-transplanted lungs.
      For negative controls, the primary antibody was replaced by bovine serum albumin.

      Laser-Assisted Microdissection and RNA Extraction

      Serial sections (5-μm–thick FFPE tissue) were mounted on a poly-l-lysine–coated membrane fixed onto a metal frame. After deparaffinization and routine (hemalum) staining, the CellCut Plus system (MMI Molecular Machines & Industries AG, Glattbrugg, Switzerland) was used for laser-assisted microdissection. Pathologic and anatomic structures (PLs, adjacent arteries, concentric lesions in patients with APAH without PLs, and controls) were sampled from at least two locations in both lobes of the explants using a no-touch technique, as described elsewhere
      • Jonigk D.
      • Lehmann U.
      • Stuht S.
      • Wilhelmi M.
      • Haverich A.
      • Kreipe H.
      • Mengel M.
      Recipient-derived neoangiogenesis of arterioles and lymphatics in quilty lesions of cardiac allografts.
      (Figure 1). These microdissected areas included the adventitia directly adjacent to the vascular structures (Figure 1). Approximately 1500 cells were harvested from each compartment. The microdissected material was subsequently suspended in a proteinase K digestion buffer by placing it directly in the adhesive cap. After overnight digestion, RNA was isolated using phenol-chloroform extraction and precipitation following the established modus operandi.
      • Theophile K.
      • Jonigk D.
      • Kreipe H.
      • Bock O.
      Amplification of mRNA from laser-microdissected single or clustered cells in formalin-fixed and paraffin-embedded tissues for application in quantitative real-time PCR.
      Figure thumbnail gr1
      Figure 1Laser-assisted microdissection. A–D: Isolation of a PL from the surrounding unagitated lung tissue by laser-assisted microdissection (the laser cut is visible in B; D shows the isolated PL in the cap). Note the adjacent artery from which the PL originates in the lower right corner in A–C. Original magnification: ×100 (A–C); ×200 (D). The IX71 microscope (Olympus Europa GmbH) with the CellCut Plus system was used for laser-assisted microdissection.

      cDNA Synthesis and Preamplification

      cDNA was synthesized using the High Capacity cDNA reverse transcription kit (Applied Biosystems, Foster City, CA) and following the manufacturer's protocol. cDNA was preamplified in 14 PCR cycles with target gene–specific PCR primers, thus increasing the sensitivity of the subsequent real-time PCR analysis several thousand-fold (decrease of CT: 14 cycles; TaqMan PreAmp master mix kit, Applied Biosystems), as previously reported.
      • Jonigk D.
      • Theophile K.
      • Hussein K.
      • Bock O.
      • Lehmann U.
      • Bockmeyer C.L.
      • Gottlieb J.
      • Fischer S.
      • Simon A.
      • Welte T.
      • Maegel L.
      • Kreipe H.
      • Laenger F.
      Obliterative airway remodelling in transplanted and non-transplanted lungs.
      • Theophile K.
      • Jonigk D.
      • Kreipe H.
      • Bock O.
      Amplification of mRNA from laser-microdissected single or clustered cells in formalin-fixed and paraffin-embedded tissues for application in quantitative real-time PCR.

      Real-Time PCR and Expression Analysis

      The preamplified cDNA from laser-microdissected samples was evaluated by real-time PCR (TaqMan 7500 real-time PCR system, Applied Biosystems, Carlsbad, CA). Quantification was performed in reactions containing preamplified cDNA, TaqMan Gene Expression Master Mix, and the individual TaqMan Gene Expression Assay (both from Applied Biosystems). A compilation of proliferation-, apoptosis-, fibrosis-, and inflammation-associated genes was selected and analyzed following the manufacturer's protocol (Table 3). For negative controls, the cDNA was replaced by water. CT values were calculated by normalization to the mean expression of three endogenous controls (POLR2A, β-GUS, and GAPDH) and were converted into 2ΔCT values using Excel 8.0 (Microsoft Corp., Redmond, WA), which were then statistically analyzed using the Mann-Whitney U-test and GraphPad Prism, version 5.0 (GraphPad Software Inc., San Diego, CA).
      • Livak K.J.
      • Schmittgen T.D.
      Analysis of relative gene expression data using real-time quantitative PCR and the 2−ΔΔ CT method.
      We considered P ≤ 0.05 to be statistically significant. Expression graphics were created using GraphPad Prism, version 5.0.
      Table 3Target and Reference Genes
      No.Target genesSynonym/full name
      1Ang-1Angiopoietin-1
      2Ang-2Angiopoietin-2
      3BMP4Bone morphogenetic protein-4
      4BMPR2Bone morphogenetic protein receptor type 2
      5CASP9Caspase-9
      6c-KITCD117
      7desDesmin
      8eNOSNitric oxide synthase 3, endothelial cell
      9FGF-2Fibroblast growth factor-2
      10HIF1aHypoxia-inducible factor 1
      11IL 1bInterleukin-1b
      12IL 6Interleukin-6
      13MMP9Matrix metalloproteinase 9
      14MMP14Matrix metalloproteinase 14
      15MYH11Smooth muscle myosin heavy chain 11
      16MYOCDMyocardin
      17NOTCH4Neurogenic locus notch homolog protein 4
      18PECAM-1CD31
      19PDGFRbβ-Type platelet-derived growth factor receptor
      20SMASmooth muscle actin
      21TGF-β1Transforming growth factor-beta 1
      22THBS1Thrombospondin-1
      23VEGF-αVascular endothelial growth factor alpha
      24VEGFR1Vascular endothelial growth factor receptor 1
      25VEGFR2Vascular endothelial growth factor receptor 2
      Reference genes
      26POLR2ARNA-polymerase 2 subunit A
      27GUSBβ-glucuronidase
      28GAPDHGlyceraldehyde-3-phosphate dehydrogenase

      Immunofluorescence Double Staining

      To confirm the findings of conventional IHC and compartment-specific mRNA expression analyses regarding endothelial and/or smooth muscle differentiation of PLs, we performed immunofluorescence double staining for CD31 and SMA, CD31 and Ki-67, and SMA and Ki-67. Serially cut 5-μm–thick FFPE slides were deparaffinized, and antigens were retrieved following the established procedure. Target structures were marked using monoclonal primary- and fluorescence-labeled secondary antibodies [Cy-conjugated AffiniPure F(ab')2 fragment antibodies (H+L); Jackson ImmunoResearch Laboratories Inc., West Grove, PA]. The nuclear structures were counterstained using DAPI (40 μg/mL; Carl Roth GmbH, Karlsruhe, Germany) before the slides were mounted.
      • Jonigk D.
      • Lehmann U.
      • Stuht S.
      • Wilhelmi M.
      • Haverich A.
      • Kreipe H.
      • Mengel M.
      Recipient-derived neoangiogenesis of arterioles and lymphatics in quilty lesions of cardiac allografts.

      GLLs in Glioblastomas

      Circumscribed peritumoral vascular formations, so-called GLLs in glioblastomas multiforme (n = 5), were identified by light microscopy. Vital nonnecrotic GLLs were stained by fluorescence IHC, followed by laser-microdissection and processing for RNA expression analysis as described previously herein for PLs.

      Three-Dimensional Reconstruction of PLs

      To further assess the structural composition of PLs, we used 30-μm-thick slides and (fluorescence) double stained them for CD31 and SMA as described previously herein. To generate three-dimensional (3-D) images of PLs, we used a microscope with an automated drive (Micro Focus, Rockville, MD) and special acquisition software (BX51 microscope and Cell P Software 3.3, Olympus Europa GmbH, Hamburg, Germany) and systematically scanned the whole width of the slides. The resulting 2-D images were merged into 3-D shapes. Unspecific, out-of-focus fluorescence was removed from the resulting 3-D images using deconvolution software (advanced maximum likelihood estimation). Images were displayed using the cell* Voxel Viewer (Olympus Europa GmbH).

      Terminal Deoxynucleotidyl Transferase–Mediated dUTP Nick-End Labeling Assay

      To analyze the role of apoptosis in the remodeling process in PLs beyond caspase mRNA expression (see previously herein), we assessed the content of fragmented DNA in PLs, adjacent vessels, and controls using an apoptosis detection kit (ApopTag plus peroxidase in situ; Millipore, Temecula, CA) on 5-μm FFPE samples following the manufacturer's protocol.

      Results

      Characterization of PLs and Neighboring Remodeled Arteries

      PLs showed significant mRNA up-regulation of the endothelial markers CD31 and endothelial nitric oxide synthase and an increase in SMA expression compared with the adjacent arteries (Figure 2). Because PLs are mainly composed of “vascular channels,” (over)expression of markers of endothelial differentiation is not surprising, especially considering the comparable numbers of microdissected cells from the different compartments.
      Figure thumbnail gr2
      Figure 2mRNA expression of target genes in PLs in APAH in alphabetical order. Comparison of mRNA expression characteristics of PLs in patients with congenital shunts between the systemic and pulmonary circulation (APAH), the adjacent arteries from which they sprout, concentric lesions in patients with APAH without PLs, and controls. Expression of target genes was calculated using the ΔCT method (see Materials and Methods for details). Middle horizontal lines indicate medians; error bars, percentiles. PDGFRb, β-type platelet-derived growth factor receptor.
      The complementary IHC staining concurred with the results of mRNA expression analysis: CD31 showed strong laminar positivity in luminal cells of vascular channels in PLs and their adjacent arteries. The staining patterns of the endothelial markers CD34 and CD141 were comparable. SMA stained strongly in the slender, nonluminal interstitium, composed of a homogenous population of tightly layered mesenchymal/myogenic cells (Figure 3 and Table 3). These staining patterns in regular IHC were confirmed using immunofluorescence double staining: the CD31-positive endothelium of the vascular channels was continuously backed by SMA-positive cells, arranged in a uniform stratum less than or equal to four cell layers thick. 3-D reconstruction of PLs validated this cellular composition (Figure 4).
      Figure thumbnail gr3
      Figure 3Protein expression of structural composition and tissue remodeling–associated markers in PLs, the adjacent arteries from which PLs originate, and GLLs in high-grade primary neural malignomas (in alphabetical order). Ang-2 showed strong cytoplasmic positivity in the endothelial/luminal compartment of PLs and also in the endothelial layer of the adjacent arteries and GLLs. c-KIT (CD117) stained positive in the endothelial/luminal compartment of PLs and in the endothelium of the adjacent arteries, whereas there was no delimitable staining in GLLs. CD31 staining was pronounced in the endothelial/luminal layers in PLs, adjacent arteries, and GLLs alike. Desmin showed only speckled cytoplasmic positivity in the interstitial/myogenic layer of PLs, whereas the media of the adjacent arteries was continuously positive and GLLs showed no staining reaction. Myocardin showed moderate cytoplasmic positivity in vascular structures in PLs and adjacent arteries, whereas GLLs stained only faintly. β-Type platelet-derived growth factor receptor (PDGFRb) stained only faintly in PLs, whereas the directly adjacent arteries showed moderate positivity, mainly at the border between the actual vascular wall and the neighboring connective tissue. GLLs showed only faint perivascular staining. Podoplanin showed no delimitable signal in PLs but a slender network of lymphatic vessels around them. There was also no positivity in the adjacent arteries or in GLLs. Staining for SMA showed slim but continuous positivity between the luminal/endothelial layers in PLs, whereas there was a prominent and homogenous staining pattern in the media of the adjacent arteries. In GLLs, the walls of the neoplastic blood vessels also showed strong cytoplasmic positivity, although it was less well organized compared with the nonneoplastic specimens/compartments. Smmhc stained weakly in the interstitium of PLs, whereas there was strong staining in the media of the adjacent arteries. GLLs displayed inhomogenous positivity of the neoplastic blood vessels. TGF-β1 stained strongly in the luminal and the interstitial compartment of PLs, whereas the adjacent arteries showed only faint positivity of the endothelium. Staining in GLLs was strong in the vascular structures. THBS1 showed inhomogenous cytoplasmic positivity in PLs, whereas the adjacent arteries showed only a faint reaction. GLLs showed inhomogenous moderate positivity. VEGF-α showed marked luminal/endothelial positivity, with only a faint endothelial signal in the adjacent arteries. The vessels in GLLs showed strong positivity. Original magnification is included in the lower right corner of each histologic image.
      Figure thumbnail gr4
      Figure 4The-3-D reconstruction of a PL. A: A fluorescent double-stained PL: the luminal vascular channels stain positive for CD31 (red) and the adjacent interstitium shows homogenous positivity for SMA (green). B: Systematically scanned images of the whole width of the PL were merged into 3-D shapes. C: Images were skeletonized into a voxel model for increased clarity. Note the distinct separation of the endothelial layer and the interstitium in the PL. D: GLLs in high-grade neural tumors show a rather disorganized composition without an equally clear separation of endothelial layer and interstitium. Original magnification: ×630 (A–C); ×1000 (D).
      The adjacent remodeled arteries with prominent media hypertrophy and intimal thickening showed significantly increased mRNA levels of desmin, myocardin, and smmhc compared with PLs (Figure 2), which was largely anticipated given the ratio of smooth muscle to endothelial cells exceeding 9:10 in these vessels. The corresponding IHC staining confirmed these expression patterns, with strong positivity in the prominent media layer for all three targets in pulmonary arteries but not in PLs. Whereas PLs, the adjacent arteries, concentric lesions in APAH without PLs, and controls did not stain for podoplanin, there was a marked accumulation of podoplanin-positive lymphatic vessels around PLs. Aside from the presence of PLs themselves, there were no reproducible morphologic differences between APAH specimens with and without PLs (Figure 3 and Table 3, Table 4).
      Table 4IHC Staining Results in Vascular Compartments
      ProteinPLsAdjacent arteriesConcentric lesions in APAH without PLsControlsGLLs
      Ang-1
       Semiquantitative score11111
       Staining intensityWeakWeakWeakWeakIntermediate
      Ang-2
       Semiquantitative score22322
       Staining intensityStrongIntermediateIntermediateWeakStrong
      c-KIT (CD117)
       Semiquantitative score11110
       Staining intensityIntermediateWeakWeakWeakAbsent
      CD141
       Semiquantitative score21112
       Staining intensityStrongStrongStrongStrongStrong
      CD31
       Semiquantitative score21112
       Staining intensityStrongStrongStrongStrongStrong
      CD34
       Semiquantitative score21112
       Staining intensityStrongIntermediateStrongStrongStrong
      Desmin
       Semiquantitative score23330
       Staining intensityIntermediateStrongStrongStrongAbsent
      Myocardin
       Semiquantitative score22321
       Staining intensityWeakIntermediateIntermediateIntermediateWeak
      PDGFRb
       Semiquantitative score22221
       Staining intensityWeakIntermediateIntermediateIntermediateWeak
      Podoplanin
       Semiquantitative score00000
       Staining intensityAbsentAbsentAbsentAbsentAbsent
      SMA
       Semiquantitative score33333
       Staining intensityStrongStrongStrongIntermediateStrong
      Smmhc
       Semiquantitative score33332
       Staining intensityIntermediateStrongStrongIntermediateIntermediate
      TGF-β1
       Semiquantitative score21112
       Staining intensityStrongWeakWeakWeakStrong
      THBS1
       Semiquantitative score21222
       Staining intensityWeakWeakIntermediateIntermediateIntermediate
      VEGF-A
       Semiquantitative score22222
       Staining intensityStrongWeakWeakIntermediateStrong
      Semiquantitative scores indicate the range of positive cells (0, no apparent reaction; 1, positivity in <30%; 2, positivity in ≥30% and <60%; and 3, positivity in ≥60%). Staining intensity is indicated as absent, weak, intermediate, or strong.
      PDGFRb, β-type platelet-derived growth factor receptor.
      Together, PLs in IPAH and APAH showed only minor differences in composition-related mRNA and protein expression: whereas PLs in APAH showed significant up-regulation of CD31, those in IPAH showed a comparable trend toward up-regulation (Figure 2, Figure 3; also see Supplemental Figure S1 and Supplemental Table S2 at http://ajp.amjpathol.org) The height of the mean pulmonary arterial pressure or the pulmonary vascular resistance measured before transplantation had no effect on the composition of PLs.

      Tissue Remodeling–Associated Markers in Pulmonary Vascular Compartments

      PLs showed significantly increased mRNA levels of Ang-2 (but not Ang-1), c-KIT, HIF1a, matrix metalloproteinase (MMP) 9 (but not MMP14), NOTCH4, VEGF-α, VEGFR1, VEGFR2, and THBS1 compared with the adjacent remodeled pulmonary arteries. We also found up-regulation of Tie-2 and pivotal TGF-β1, which do not represent endothelial growth promoters per se compared with the adjacent remodeled pulmonary arteries.
      IHC staining correlated with these findings, with strong luminal/endothelial positivity for Ang-2, c-KIT, VEGF-α, and TGF-β1 in PLs but not in the adjacent vessels. TGF-β1 also showed mild staining of the interstitium in PLs.
      BMP-4 and BMPR2 were significantly up-regulated in concentric lesions in patients with APAH who did not exhibit PLs compared with other groups. All other markers did not show significant differences between compartments/groups (Figure 2, Figure 3 and Table 3, Table 4).
      In summary, PLs in IPAH and APAH showed only minor differences in remodeling-associated gene regulation: cKIT, HIF1a, MMP9, TGF-β1, and THBS1 were up-regulated in PLs in APAH compared with the adjacent arteries, with a comparable but nonsignificant trend in PLs in IPAH (see Supplemental Figure S1 at http://ajp.amjpathol.org). Hemodynamic variables, such as the height of the mean pulmonary arterial pressure or pulmonary vascular resistance measured before transplantation, had no effect on remodeling-associated gene expression in PLs.

      Proliferation and Apoptosis in PLs

      Conventional IHC Ki-67 staining and immunofluorescence double staining for CD31/Ki-67 and SMA/Ki-67 showed a significant proliferation of CD31-positive endothelial and, to a lesser extent, SMA-positive interstitial cells in PLs compared with their adjacent pulmonary arteries (arithmetic mean ± SD: CD31+ cells in PLs, 8.2% ± 2.7%; SMA+ cells in PLs, 4.6% ± 2.2%; CD31+ cells in adjacent arteries, 1.1% ± 1.1%; and SMA+ cells in adjacent arteries, 1.2% ± 0.9%). We found no significant differences regarding apoptosis in mRNA expression analysis of caspases or terminal deoxynucleotidyl transferase–mediated dUTP nick-end labeling assays between PLs and the adjacent arteries or external controls (PLs, <0.5% positive; adjacent arteries, <0.5% positive) (Figure 5).
      Figure thumbnail gr5
      Figure 5Proliferation and apoptosis in PLs in APAH. IHC staining for the proliferation marker Ki-67 in PLs (A) and the adjacent arteries (B). Whereas there is marked proliferation in PLs, only single cells of the endothelium stain positive in the adjacent arteries. Terminal deoxynucleotidyl transferase–mediated dUTP nick-end labeling (TUNEL) assays do not show significant degrees of apoptosis in PLs (C) or the adjacent arteries (D), and neither is there significant mRNA up-regulation of apoptosis-associated caspase 9 (CASP9) (E). Middle horizontal lines indicate medians; error bars, percentiles. Original magnification, ×100 (A–D).
      There were only minor differences regarding the ratio of proliferation and apoptosis between PLs in IPAH and APAH: caspase 9 showed barely significant down-regulation in PLs in IPAH cases compared with the adjacent arteries (see Supplemental Figure S1 at http://ajp.amjpathol.org), whereas mRNA expression levels in PLs and adjacent arteries were similar in APAH specimens (Figure 2).

      Inflammatory Cells in PLs

      CD3-positive T lymphocytes represented most inflammatory cells in PLs (arithmetic mean ± SD, 7.7% ± 6.7% of all cells in PLs). They also accumulated directly adjacent to PLs, where we found networks of podoplanin-positive lymphatic vessels (see previously herein). CD20-positive B lymphocytes accounted for only a few leukocytes in PLs (arithmetic mean ± SD: 1% ± 0.9% of all cells in PLs). CD68-positive macrophages (arithmetic mean ± SD: 6.2% ± 1.9% of all cells in PLs) and mast cells (arithmetic mean ± SD: 3.6% ± 3.4% of all cells in PL) showed an approximately equal distribution in PLs. The adjacent pulmonary arteries showed <1% CD3-, CD20-, CD68-, and mast cell tryptase–positive cells (Figure 6). PLs in IPAH and APAH showed no significant differences in concentrations of inflammatory cells.
      Figure thumbnail gr6
      Figure 6Inflammatory cells in PLs. Most inflammatory cells in PLs are CD3-positive T lymphocytes, which also accumulate around PLs (A). CD20-positive B lymphocytes account for only a few leukocytes in PLs (B). CD68-positive macrophages (C) and mast cells (D) show an almost equal distribution in PLs. Original magnification, ×100 (A–D).

      PAH with BMPR2 Mutation and PLs

      The PL in the one patient with a known BMPR2 mutation did not differ from the PL in the other patients with IPAH and APAH: no differences regarding expression patterns (mRNA and IHC analysis), structural composition, or cellularity could be found (see Supplemental Figure S1 at http://ajp.amjpathol.org).

      Characterization of GLLs

      Whereas PLs in patients with PAH were well structured, with a layered composition of CD34-positive endothelium and SMA-positive interstitium ≤4 cell layers (see previously herein), the endothelium and media of the vessels that compose GLLs were irregularly shaped and contorted. The thickness of the media/smooth muscle interstitium in GLLs varied considerably and frequently exceeded six layers. PLs showed significant up-regulation of desmin, myocardin, and smmhc compared with GLLs. The corresponding IHC for all three proteins confirmed faint staining of desmin, myocardin, and smmhc in GLLs, whereas staining was moderate in PLs (Figure 3, Figure 4 and Table 4).

      Comparison of Angiogenic Markers in PLs and GLLs in Glioblastomas

      Compared with PLs, GLLs showed significant mRNA up-regulation of Ang-2, MMP9, and VEGFR2, whereas PLs showed up-regulation of Ang-2, BMPR2, endothelial nitric oxide synthase, and Tie-2. IHC analysis of Ang-1 and Ang-2 matched these findings, with strong expression of Ang-2 in PLs and intermediate staining intensity for Ang-1 in GLLs in glioblastomas. All other markers showed no significant differences between PLs and GLLs (Figure 7 and Table 5, Table 6).
      Figure thumbnail gr7
      Figure 7mRNA expression of target genes in PLs in APAH and GLLs in alphabetical order. Comparison of selected mRNA expression characteristics of PLs in patients with congenital shunts between the systemic and pulmonary circulation (APAH) and GLLs in high-grade primary neural tumors. Expression of target genes was calculated using the ΔCT method (see Materials and Methods for details). Lines indicate medians; error bars, percentiles.
      Table 5mRNA Expression in PLs in APAH and the Adjacent Arteries from Which They Sprout
      GeneP value
      PLs (APAH)Adjacent arteries
      Ang-1NSNS
      Ang-2<0.05
      BMP4NSNS
      BMPR2NSNS
      CASP9NSNS
      CD31<0.001
      cKIT<0.01
      Des<0.01
      eNOS<0.05
      FGF-2NSNS
      HIF1a<0.05
      IL-1bNSNS
      IL-6NSNS
      MMP9<0.05
      MMP14NSNS
      Myocardin<0.05
      NOTCH4<0.05
      PDGFRbNSNS
      SMA<0.05
      Smmhc<0.05
      TGF-β1<0.05
      THBS1<0.05
      Tie2<0.001
      VEGF-α<0.01
      VEGFR1<0.05
      VEGFR2<0.01
      Table 6mRNA Expression in PLs in APAH and GLLs in High-Grade Glial Neoplasms
      GeneP value
      PLs (APAH)GLLs
      Ang-1<0.01
      Ang-2<0.01
      BMPR2<0.01
      CD31NSNS
      cKITNSNS
      Des<0.01
      eNOS<0.01
      FGF-2NSNS
      HIF1aNSNS
      IL-1bNSNS
      IL-6NSNS
      MMP9<0.05
      MMP14NSNS
      Myocardin<0.01
      NOTCH4NSNS
      PDGFRbNSNS
      SMANSNS
      Smmhc<0.01
      TGF-β1NSNS
      THBS1NSNS
      Tie2<0.001
      VEGF-αNSNS
      VEGFR1NSNS
      VEGFR2<0.01

      Discussion

      Complex vascular formations, so-called PLs, are histologic hallmarks of lungs from patients with PAH. Whether they represent morphologic sequelae of the raised intravascular pressure or actively contribute to the course of the disease is still debated; per se, both seem possible.
      • Fishman A.P.
      Changing concepts of the pulmonary plexiform lesion.
      • Crosby A.
      • Jones F.M.
      • Southwood M.
      • Stewart S.
      • Schermuly R.
      • Butrous G.
      • Dunne D.W.
      • Morrell N.W.
      Pulmonary vascular remodeling correlates with lung eggs and cytokines in murine schistosomiasis.
      • Toshner M.
      • Voswinckel R.
      • Southwood M.
      • Al-Lamki R.
      • Howard L.S.
      • Marchesan D.
      • Yang J.
      • Suntharalingam J.
      • Soon E.
      • Exley A.
      • Stewart S.
      • Hecker M.
      • Zhu Z.
      • Gehling U.
      • Seeger W.
      • Pepke-Zaba J.
      • Morrell N.W.
      Evidence of dysfunction of endothelial progenitors in pulmonary arterial hypertension.
      PLs are generally thought to originate from a misled neoangiogenesis with a dysbalance between apoptosis/necrosis and subsequent proliferation of the endothelium.
      • Sakao S.
      • Tatsumi K.
      • Voelkel N.F.
      Endothelial cells and pulmonary arterial hypertension: apoptosis, proliferation, interaction and transdifferentiation.
      Although PLs and their development over time have been studied in animal experiments and in part in in vitro settings, knowledge about PLs in the human lung is still limited.
      Although they are end-stage organs, recipient lung explants sampled at the date of transplantation represent the only feasible source of lung tissue with characteristic histologic changes of severe PAH in humans. Transbronchial or wedge biopsies are not obtained in day-to-day routine from patients with PAH; in fact, for the most part, the latter are contraindicated owing to considerable bleeding risk, and material taken during postmortem examinations is usually unsuitable for an extensive molecular workup.
      From a morphologic point of view, using fluorescent double staining and regular IHC analysis and 3-D reconstruction, these results reveal that PLs are highly ordered structures. The thin, luminal layer around vascular channels was composed of a homogeneous population of CD31-, CD34-, and CD141-positive endothelial cells. This concurs with the mRNA up-regulation of CD31 and endothelial nitric oxide synthase, which suggests prominent endothelial differentiation and further extends previous findings describing endothelial cells as the predominant, if not only, cell type composing PLs. We found no thrombi in any of the PLs we examined. This suggests an intact intima/endothelium with a predominantly nonturbulent flow.
      • Stevens T.
      Molecular and cellular determinants of lung endothelial cell heterogeneity.
      We also found a distinct interstitial compartment in PLs, separating the individual blood channels from each other. It was composed of a thin, uniform layer of mesenchymal cells with myogenic differentiation (“interstitial cells of myogenic phenotype”). These cells showed prominent up-regulation of SMA, even compared with the adjacent remodeled arteries, which had prominent media and intima and, thus, consisted mainly of smooth muscle cells. There was, however, only limited expression of smmhc and, notably, desmin. As the concentration of these intermediary filament increases with advancing differentiation of smooth muscle cells toward a contractile phenotype,
      • Rensen S.S.
      • Doevendans P.A.
      • van Eys G.J.
      Regulation and characteristics of vascular smooth muscle cell phenotypic diversity.
      • Gerthoffer W.T.
      Mechanisms of vascular smooth muscle cell migration.
      we consider the heterogeneous expression pattern an indicator of an intermediate state between the contractile and synthetic phenotypes, a finding that is consistent with IHC staining patterns described by others in postmortem case studies in lungs of patients with PAH.
      • Mitani Y.
      • Ueda M.
      • Komatsu R.
      • Maruyama K.
      • Nagai R.
      • Matsumura M.
      • Sakurai M.
      Vascular smooth muscle cell phenotypes in primary pulmonary hypertension.
      Whereas synthetic differentiation tends toward increased proliferation and migration, the contractile phenotype is associated with structural integrity. Both are needed for progressive vascular remodeling.
      • Rensen S.S.
      • Doevendans P.A.
      • van Eys G.J.
      Regulation and characteristics of vascular smooth muscle cell phenotypic diversity.
      Because remodeling in PAH lungs affects all precapillary vascular compartments, from the truncus pulmonalis down to the arterioles, the question arises as to why the remodeling process is especially pronounced and intricate in PLs. The low expression levels of myocardin and smmhc (but not of β-type platelet-derived growth factor receptor) in PLs might provide an answer: these three proteins are characteristic of pericytes. In this line, knockout experiments showed that the absence of these regulatory perivascular cells indeed promotes abundant endothelial hyperplasia in smaller vessels.
      • Jones R.
      • Capen D.
      • Jacobson M.
      PDGF and microvessel wall remodeling in adult lung: imaging PDGF-Rβ and PDGF-BB molecules in progenitor smooth muscle cells developing in pulmonary hypertension.
      • Assaad A.M.
      • Kawut S.M.
      • Arcasoy S.M.
      • Rosenzweig E.B.
      • Wilt J.S.
      • Sonett J.R.
      • Borczuk A.C.
      Platelet-derived growth factor is increased in pulmonary capillary hemangiomatosis.
      • Zhu P.
      • Huang L.
      • Ge X.
      • Yan F.
      • Wu R.
      • Ao Q.
      Transdifferentiation of pulmonary arteriolar endothelial cells into smooth muscle-like cells regulated by myocardin involved in hypoxia-induced pulmonary vascular remodelling.
      A possible “outgrowth” of the vascular channels in PLs, with which the regulatory pericytes did not keep pace, might lead to a relative lack of pericytes in PLs. Thus, aside from local hypoxia and shear forces, lack of superordinate regulation might contribute to the ongoing remodeling in PAH lungs. Because pericytes possess considerable plasticity, they cannot be definitely characterized by mRNA and protein expression, thus severely hampering the analysis of their involvement in the formation of PLs.
      • Kutcher M.E.
      • Herman I.M.
      The pericyte: cellular regulator of microvascular blood flow.
      • Kennedy A.
      • Ng C.T.
      • Biniecka M.
      • Saber T.
      • Taylor C.
      • O'Sullivan J.
      • Veale D.J.
      • Fearon U.
      Angiogenesis and blood vessel stability in inflammatory arthritis.
      • Raza A.
      • Franklin M.J.
      • Dudek A.Z.
      Pericytes and vessel maturation during tumor angiogenesis and metastasis.
      We repeatedly found delicate networks of lymphatic vessels surrounding the PLs, mainly populated by T lymphocytes, presumably identical to “clusters of inflammatory cells” identified by others.
      • Angelini D.J.
      • Su Q.
      • Yamaji-Kegan K.
      • Fan C.
      • Teng X.
      • Hassoun P.M.
      • Yang S.C.
      • Champion H.C.
      • Tuder R.M.
      • Johns R.A.
      Resistin-like molecule-β in scleroderma-associated pulmonary hypertension.
      • Carreira P.E.
      Pulmonary hypertension in autoimmune rheumatic diseases.
      In the PL, no lymphatics could be shown. Although elevated serum levels of ILs in patients with PAH have been described, there was no increased expression of ILs in the vascular compartments examined.
      • Hecker M.
      • Zaslona Z.
      • Kwapiszewska G.
      • Niess G.
      • Zakrzewicz A.
      • Hergenreider E.
      • Wilhelm J.
      • Marsh L.M.
      • Sedding D.
      • Klepetko W.
      • Lohmeyer J.
      • Dimmeler S.
      • Seeger W.
      • Weissmann N.
      • Schermuly R.T.
      • Kneidinger N.
      • Eickelberg O.
      • Morty R.E.
      Dysregulation of the IL-13 receptor system: a novel pathomechanism in pulmonary arterial hypertension.
      Although these specimens represent end-stage organs in severely ill patients, PLs still displayed a marked degree of ongoing remodeling. There was pronounced proliferation of endothelial cells, but we observed only a limited extent of cell division in the muscular interstitium. We found almost no detectable apoptosis in either cell type. This concurs with findings of others, who postulate PLs as a result of focal arterial wall apoptosis/necrosis. This initial selection process is thought to leave a circumscript aggregate or remnant of apoptosis-resistant endothelial cells, which compose and promote the growth and reshaping of PLs.
      • Sakao S.
      • Tatsumi K.
      • Voelkel N.F.
      Endothelial cells and pulmonary arterial hypertension: apoptosis, proliferation, interaction and transdifferentiation.
      This continuous proliferation with invagination and sprouting of vascular channels was mirrored by an increased expression of MMP9 and NOTCH4. Of these, the former is involved in the remodeling of the basement membrane during the sprouting process and the latter is involved in the cross talk with pivotal VEGF-α and TGF-β1, the smooth muscle layers and the endothelium, which also drives the reshaping of the local vasculature.
      • van Hinsbergh V.W.
      • Koolwijk P.
      Endothelial sprouting and angiogenesis: matrix metalloproteinases in the lead.
      • Holderfield M.T.
      • Hughes C.C.
      Crosstalk between vascular endothelial growth factor, notch, and transforming growth factor-β in vascular morphogenesis.
      • Merks R.M.
      • Perryn E.D.
      • Shirinifard A.
      • Glazier J.A.
      Contact-inhibited chemotaxis in de novo and sprouting blood-vessel growth.
      The tissue remodeling–associated microenvironment in PLs in PAH is complex. We found significant up-regulation of hypoxia and shear stress–induced angiogenic mediators, such as HIF1a, VEGF-α and its corresponding receptors (VEGFR1 and VEGFR2), Ang-1, Tie-2, and THBS1 but also of c-KIT in PLs. Considering the importance of these pathways for angiogenesis in general, and particularly for the remodeling of the pulmonary blood vessels, up-regulation in PAH lungs per se is principally not surprising. These markers have been demonstrated to be elevated in different organs and the peripheral bloodstream of patients with PAH and in animal models, where especially the induction of the VEGF pathway correlated with the severity of PAH and, accordingly, survival.
      • Ochoa C.D.
      • Yu L.
      • Al-Ansari E.
      • Hales C.A.
      • Quinn D.A.
      Thrombospondin-1 null mice are resistant to hypoxia-induced pulmonary hypertension.
      • Liu A.
      • Mosher D.F.
      • Murphy-Ullrich J.E.
      • Goldblum S.E.
      The counteradhesive proteins, thrombospondin 1 and SPARC/osteonectin, open the tyrosine phosphorylation-responsive paracellular pathway in pulmonary vascular endothelia.
      • Papaioannou A.I.
      • Zakynthinos E.
      • Kostikas K.
      • Kiropoulos T.
      • Koutsokera A.
      • Ziogas A.
      • Koutroumpas A.
      • Sakkas L.
      • Gourgoulianis K.I.
      • Daniil Z.D.
      Serum VEGF levels are related to the presence of pulmonary arterial hypertension in systemic sclerosis.
      • Kumpers P.
      • Nickel N.
      • Lukasz A.
      • Golpon H.
      • Westerkamp V.
      • Olsson K.M.
      • Jonigk D.
      • Maegel L.
      • Bockmeyer C.L.
      • David S.
      • Hoeper M.M.
      Circulating angiopoietins in idiopathic pulmonary arterial hypertension.
      • Ito C.
      • Akimoto T.
      • Ioka T.
      • Kobayashi T.
      • Kusano E.
      TGF-β inhibits vascular sprouting through TGF-β type I receptor in the mouse embryonic aorta.
      Their concerted up-regulation in PLs, especially compared with the adjacent remodeled arteries/concentric lesions, is, however, interesting. Although it is unlikely that lesions that arise as late in the course of a disease as PLs do in PAH,
      • Abe M.
      • Kimura T.
      • Morimoto T.
      • Taniguchi T.
      • Yamanaka F.
      • Nakao K.
      • Yagi N.
      • Kokubu N.
      • Kasahara Y.
      • Kataoka Y.
      • Otsuka Y.
      • Kawamura A.
      • Miyazaki S.
      • Horiuchi K.
      • Ito A.
      • Hoshizaki H.
      • Kawaguchi R.
      • Setoguchi M.
      • Inada T.
      • Kishi K.
      • Sakamoto H.
      • Morioka N.
      • Imai M.
      • Shiomi H.
      • Nonogi H.
      • Mitsudo K.
      Sirolimus-eluting stent versus balloon angioplasty for sirolimus-eluting stent restenosis: insights from the j-Cypher Registry.
      and by no means occur in every patient with PAH,
      • Pietra G.G.
      • Edwards W.D.
      • Kay J.M.
      • Rich S.
      • Kernis J.
      • Schloo B.
      • Ayres S.M.
      • Bergofsky E.H.
      • Brundage B.H.
      • Detre K.M.
      Histopathology of primary pulmonary hypertension: a qualitative and quantitative study of pulmonary blood vessels from 58 patients in the National Heart, Lung, and Blood Institute, Primary Pulmonary Hypertension Registry.
      are involved in the onset of the condition, they might well contribute to its sustainment as a source of mediators guiding vascular remodeling in other anatomic sites of the lung.
      In contrast, the universally low mitotic rate and low expression of angiogenic/remodeling-associated markers in the arteries from which PLs arise do not support the concept of a circumscript “angiogenic niche” that harbors cells with a quasi neoplastic behavior in these adjacent vessels. Rather, we consider the sprouting of PLs to be an overshooting regenerative process and not a neoplastic event sensu stricto.
      Significant up-regulation of hypoxemia-induced genes in the control group is explained by the cold ischemia to which the grafts, from which the downsizing-specimens were sampled before transplantation, were exposed while being transported to and prepared for the organ recipient.
      • Jayle C.
      • Favreau F.
      • Zhang K.
      • Doucet C.
      • Goujon J.M.
      • Hebrard W.
      • Carretier M.
      • Eugene M.
      • Mauco G.
      • Tillement J.P.
      • Hauet T.
      Comparison of protective effects of trimetazidine against experimental warm ischemia of different durations: early and long-term effects in a pig kidney model.
      • Lario S.
      • Bescos M.
      • Campos B.
      • Mur C.
      • Luque P.
      • Alvarez R.
      • Campistol J.M.
      Thrombospondin-1 mRNA expression in experimental kidney transplantation with heart-beating and non-heart-beating donors.
      Recipient lungs with hypertension-induced changes, on the other hand, did not undergo cold ischemia but were fixated directly after explantation.
      We found significant up-regulation of BMP-4 and BMPR2 in concentric lesions in remodeled pulmonary arteries of patients with APAH but not in cases with PLs. These proteins were originally named for their ability to facilitate bone tissue formation, but more recently their involvement in the signaling balance in lung development and fibrosis has been demonstrated: whereas the cross talk between BMPs and other members of the TGF superfamily is yet to be fully elucidated, various interactions, such as shared receptors and competition for subordinate SMADs, have been described, which for the most part serve the maintenance of tissue homeostasis.
      • Pegorier S.
      • Campbell G.A.
      • Kay A.B.
      • Lloyd C.M.
      Bone morphogenetic protein (BMP)-4 and BMP-7 regulate differentially transforming growth factor (TGF)-β1 in normal human lung fibroblasts (NHLF).
      Elevated but also decreased levels of BMPs have been described in patients with tissue remodeling in different organs, and in vitro studies have attributed BMPs with a degree of protective properties.
      • Wang S.
      • de Caestecker M.
      • Kopp J.
      • Mitu G.
      • Lapage J.
      • Hirschberg R.
      Renal bone morphogenetic protein-7 protects against diabetic nephropathy.
      • Reynolds A.M.
      • Xia W.
      • Holmes M.D.
      • Hodge S.J.
      • Danilov S.
      • Curiel D.T.
      • Morrell N.W.
      • Reynolds P.N.
      Bone morphogenetic protein type 2 receptor gene therapy attenuates hypoxic pulmonary hypertension.
      In the lung, aberrant BMP expression due to inactivation of the BMPR2 gene has been shown to lead to a disorganized proliferation of smooth muscle cells and to contribute to the development of PAH.
      • Machado R.D.
      • Eickelberg O.
      • Elliott C.G.
      • Geraci M.W.
      • Hanaoka M.
      • Loyd J.E.
      • Newman J.H.
      • Phillips III, J.A.
      • Soubrier F.
      • Trembath R.C.
      • Chung W.K.
      Genetics and genomics of pulmonary arterial hypertension.
      Although the pathophysiologic significance of the BMPR2 mutation in IPAH has been proved, we could not find an effect on the morphology and composition of PLs.
      Because neoangiogenesis in high-grade glial neoplasms (so-called GLLs) and PLs share a related morphology, they have been proposed as a putative model for PLs.
      • Tuder R.M.
      • Voelkel N.F.
      Plexiform lesion in severe pulmonary hypertension: association with glomeruloid lesion.
      • Ricci-Vitiani L.
      • Pallini R.
      • Biffoni M.
      • Todaro M.
      • Invernici G.
      • Cenci T.
      • Maira G.
      • Parati E.A.
      • Stassi G.
      • Larocca L.M.
      • De Maria R.
      Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells.
      In (fluorescent) IHC staining, we found blood vessels in GLLs to have a prominent variation in thickness and layering compared with PLs. A continuous myogenic layer separating the endothelium of individual channels was not always discernible in GLLs. Furthermore, compared with GLLs, PLs showed significant up-regulation of desmin, myocardin, and smmhc (but not of SMA). Thus, according to the yardstick discussed previously herein, smooth muscle cells in GLLs show a different phenotypic differentiation than do PLs.
      • Rensen S.S.
      • Doevendans P.A.
      • van Eys G.J.
      Regulation and characteristics of vascular smooth muscle cell phenotypic diversity.
      With an up-regulation of Ang-2 and Tie-2 in PLs, but Ang-2 and VEGFR2 in GLLs, remodeling-associated markers also differed significantly. Because of these apparent differences, we feel that neoplastic models, such as GLLs, will be of limited use in the further study of plexiform vasculopathy.
      In conclusion, we found PLs to be well-organized structures with a distinct microenvironment that sets them apart from the remodeled arteries in PAH lungs. The present results imply that PLs represent a complex, multifactorial epiphenomenon with shared characteristics in APAH and IPAH. Aside from studies in the human setting, preference should be given to animal models, which, in contrast to neoplastic models, can depict the hemodynamic aspects of PAH.
      • Stenmark K.R.
      • Meyrick B.
      • Galie N.
      • Mooi W.J.
      • McMurtry I.F.
      Animal models of pulmonary arterial hypertension: the hope for etiological discovery and pharmacological cure.

      Acknowledgments

      We thank Dr. Carsten in der Wiesche and Matthias Ernst (Olympus Europa GmbH) for their excellent technical support and Gillian Teicke for editing the text.

      Supplementary data

      • Supplemental Figure S1

        Comparison of mRNA expression characteristics of PLs in patients with IPAH, the adjacent arteries from which they sprout, concentric lesions in patients with APAH without PLs, and controls. Expression of target genes was calculated using the Δ CT method (see Materials and Methods for details). Thick dotted line indicates the expression levels of the one patient with a known BMPR2 mutation; thin lines, medians.

      References

        • Simonneau G.
        • Galie N.
        • Rubin L.J.
        • Langleben D.
        • Seeger W.
        • Domenighetti G.
        • Gibbs S.
        • Lebrec D.
        • Speich R.
        • Beghetti M.
        • Rich S.
        • Fishman A.
        Clinical classification of pulmonary hypertension.
        J Am Coll Cardiol. 2004; 43: 5S-12S
        • Firth A.L.
        • Mandel J.
        • Yuan J.X.
        Idiopathic pulmonary arterial hypertension.
        Dis Model Mech. 2010; 3: 268-273
        • Sakao S.
        • Tatsumi K.
        • Voelkel N.F.
        Endothelial cells and pulmonary arterial hypertension: apoptosis, proliferation, interaction and transdifferentiation.
        Respir Res. 2009; 10: 95
        • Pietra G.G.
        • Edwards W.D.
        • Kay J.M.
        • Rich S.
        • Kernis J.
        • Schloo B.
        • Ayres S.M.
        • Bergofsky E.H.
        • Brundage B.H.
        • Detre K.M.
        Histopathology of primary pulmonary hypertension: a qualitative and quantitative study of pulmonary blood vessels from 58 patients in the National Heart, Lung, and Blood Institute, Primary Pulmonary Hypertension Registry.
        Circulation. 1989; 80: 1198-1206
        • Stevens T.
        Molecular and cellular determinants of lung endothelial cell heterogeneity.
        Chest. 2005; 128: 558S-564S
        • Owens G.K.
        • Kumar M.S.
        • Wamhoff B.R.
        Molecular regulation of vascular smooth muscle cell differentiation in development and disease.
        Physiol Rev. 2004; 84: 767-801
        • Cool C.D.
        • Stewart J.S.
        • Werahera P.
        • Miller G.J.
        • Williams R.L.
        • Voelkel N.F.
        • Tuder R.M.
        Three-dimensional reconstruction of pulmonary arteries in plexiform pulmonary hypertension using cell-specific markers: evidence for a dynamic and heterogeneous process of pulmonary endothelial cell growth.
        Am J Pathol. 1999; 155: 411-419
        • Abe K.
        • Toba M.
        • Alzoubi A.
        • Ito M.
        • Fagan K.A.
        • Cool C.D.
        • Voelkel N.F.
        • McMurtry I.F.
        • Oka M.
        Formation of plexiform lesions in experimental severe pulmonary arterial hypertension.
        Circulation. 2010; 121: 2747-2754
        • Abe M.
        • Kimura T.
        • Morimoto T.
        • Taniguchi T.
        • Yamanaka F.
        • Nakao K.
        • Yagi N.
        • Kokubu N.
        • Kasahara Y.
        • Kataoka Y.
        • Otsuka Y.
        • Kawamura A.
        • Miyazaki S.
        • Horiuchi K.
        • Ito A.
        • Hoshizaki H.
        • Kawaguchi R.
        • Setoguchi M.
        • Inada T.
        • Kishi K.
        • Sakamoto H.
        • Morioka N.
        • Imai M.
        • Shiomi H.
        • Nonogi H.
        • Mitsudo K.
        Sirolimus-eluting stent versus balloon angioplasty for sirolimus-eluting stent restenosis: insights from the j-Cypher Registry.
        Circulation. 2010; 122: 42-51
        • Tuder R.M.
        • Voelkel N.F.
        Plexiform lesion in severe pulmonary hypertension: association with glomeruloid lesion.
        Am J Pathol. 2001; 159: 382-383
        • Skuli N.
        • Liu L.
        • Runge A.
        • Wang T.
        • Yuan L.
        • Patel S.
        • Iruela-Arispe L.
        • Simon M.C.
        • Keith B.
        Endothelial deletion of hypoxia-inducible factor-2α (HIF-2α) alters vascular function and tumor angiogenesis.
        Blood. 2009; 114: 469-477
        • Sakao S.
        • Tatsumi K.
        The effects of antiangiogenic compound SU5416 in a rat model of pulmonary arterial hypertension.
        Respiration. 2011; 81: 253-261
        • Tuder R.M.
        • Groves B.
        • Badesch D.B.
        • Voelkel N.F.
        Exuberant endothelial cell growth and elements of inflammation are present in plexiform lesions of pulmonary hypertension.
        Am J Pathol. 1994; 144: 275-285
        • Rai P.R.
        • Cool C.D.
        • King J.A.
        • Stevens T.
        • Burns N.
        • Winn R.A.
        • Kasper M.
        • Voelkel N.F.
        The cancer paradigm of severe pulmonary arterial hypertension.
        Am J Respir Crit Care Med. 2008; 178: 558-564
        • Heath D.
        • Edwards J.E.
        The pathology of hypertensive pulmonary vascular disease: a description of six grades of structural changes in the pulmonary arteries with special reference to congenital cardiac septal defects.
        Circulation. 1958; 18: 533-547
        • Ruschoff J.
        • Dietel M.
        • Baretton G.
        • Arbogast S.
        • Walch A.
        • Monges G.
        • Chenard M.P.
        • Penault-Llorca F.
        • Nagelmeier I.
        • Schlake W.
        • Hofler H.
        • Kreipe H.H.
        HER2 diagnostics in gastric cancer-guideline validation and development of standardized immunohistochemical testing.
        Virchows Arch. 2010; 457: 299-307
        • Jonigk D.
        • Merk M.
        • Hussein K.
        • Maegel L.
        • Theophile K.
        • Muth M.
        • Lehmann U.
        • Bockmeyer C.L.
        • Mengel M.
        • Gottlieb J.
        • Welte T.
        • Haverich A.
        • Golpon H.
        • Kreipe H.
        • Laenger F.
        Obliterative airway remodeling molecular evidence for shared pathways in transplanted and native lungs.
        Am J Pathol. 2011; 178: 599-608
        • Jonigk D.
        • Theophile K.
        • Hussein K.
        • Bock O.
        • Lehmann U.
        • Bockmeyer C.L.
        • Gottlieb J.
        • Fischer S.
        • Simon A.
        • Welte T.
        • Maegel L.
        • Kreipe H.
        • Laenger F.
        Obliterative airway remodelling in transplanted and non-transplanted lungs.
        Virchows Arch. 2010; 457: 369-380
        • Jonigk D.
        • Lehmann U.
        • Stuht S.
        • Wilhelmi M.
        • Haverich A.
        • Kreipe H.
        • Mengel M.
        Recipient-derived neoangiogenesis of arterioles and lymphatics in quilty lesions of cardiac allografts.
        Transplantation. 2007; 84: 1335-1342
        • Theophile K.
        • Jonigk D.
        • Kreipe H.
        • Bock O.
        Amplification of mRNA from laser-microdissected single or clustered cells in formalin-fixed and paraffin-embedded tissues for application in quantitative real-time PCR.
        Diagn Mol Pathol. 2008; 17: 101-106
        • Livak K.J.
        • Schmittgen T.D.
        Analysis of relative gene expression data using real-time quantitative PCR and the 2−ΔΔ CT method.
        Methods. 2001; 25: 402-408
        • Fishman A.P.
        Changing concepts of the pulmonary plexiform lesion.
        Physiol Res. 2000; 49: 485-492
        • Crosby A.
        • Jones F.M.
        • Southwood M.
        • Stewart S.
        • Schermuly R.
        • Butrous G.
        • Dunne D.W.
        • Morrell N.W.
        Pulmonary vascular remodeling correlates with lung eggs and cytokines in murine schistosomiasis.
        Am J Respir Crit Care Med. 2010; 181: 279-288
        • Toshner M.
        • Voswinckel R.
        • Southwood M.
        • Al-Lamki R.
        • Howard L.S.
        • Marchesan D.
        • Yang J.
        • Suntharalingam J.
        • Soon E.
        • Exley A.
        • Stewart S.
        • Hecker M.
        • Zhu Z.
        • Gehling U.
        • Seeger W.
        • Pepke-Zaba J.
        • Morrell N.W.
        Evidence of dysfunction of endothelial progenitors in pulmonary arterial hypertension.
        Am J Respir Crit Care Med. 2009; 180: 780-787
        • Rensen S.S.
        • Doevendans P.A.
        • van Eys G.J.
        Regulation and characteristics of vascular smooth muscle cell phenotypic diversity.
        Neth Heart J. 2007; 15: 100-108
        • Gerthoffer W.T.
        Mechanisms of vascular smooth muscle cell migration.
        Circ Res. 2007; 100: 607-621
        • Mitani Y.
        • Ueda M.
        • Komatsu R.
        • Maruyama K.
        • Nagai R.
        • Matsumura M.
        • Sakurai M.
        Vascular smooth muscle cell phenotypes in primary pulmonary hypertension.
        Eur Respir J. 2001; 17: 316-320
        • Jones R.
        • Capen D.
        • Jacobson M.
        PDGF and microvessel wall remodeling in adult lung: imaging PDGF-Rβ and PDGF-BB molecules in progenitor smooth muscle cells developing in pulmonary hypertension.
        Ultrastruct Pathol. 2006; 30: 267-281
        • Assaad A.M.
        • Kawut S.M.
        • Arcasoy S.M.
        • Rosenzweig E.B.
        • Wilt J.S.
        • Sonett J.R.
        • Borczuk A.C.
        Platelet-derived growth factor is increased in pulmonary capillary hemangiomatosis.
        Chest. 2007; 131: 850-855
        • Zhu P.
        • Huang L.
        • Ge X.
        • Yan F.
        • Wu R.
        • Ao Q.
        Transdifferentiation of pulmonary arteriolar endothelial cells into smooth muscle-like cells regulated by myocardin involved in hypoxia-induced pulmonary vascular remodelling.
        Int J Exp Pathol. 2006; 87: 463-474
        • Kutcher M.E.
        • Herman I.M.
        The pericyte: cellular regulator of microvascular blood flow.
        Microvasc Res. 2009; 77: 235-246
        • Kennedy A.
        • Ng C.T.
        • Biniecka M.
        • Saber T.
        • Taylor C.
        • O'Sullivan J.
        • Veale D.J.
        • Fearon U.
        Angiogenesis and blood vessel stability in inflammatory arthritis.
        Arthritis Rheum. 2010; 62: 711-721
        • Raza A.
        • Franklin M.J.
        • Dudek A.Z.
        Pericytes and vessel maturation during tumor angiogenesis and metastasis.
        Am J Hematol. 2010; 85: 593-598
        • Angelini D.J.
        • Su Q.
        • Yamaji-Kegan K.
        • Fan C.
        • Teng X.
        • Hassoun P.M.
        • Yang S.C.
        • Champion H.C.
        • Tuder R.M.
        • Johns R.A.
        Resistin-like molecule-β in scleroderma-associated pulmonary hypertension.
        Am J Respir Cell Mol Biol. 2009; 41: 553-561
        • Carreira P.E.
        Pulmonary hypertension in autoimmune rheumatic diseases.
        Autoimmun Rev. 2004; 3: 313-320
        • Hecker M.
        • Zaslona Z.
        • Kwapiszewska G.
        • Niess G.
        • Zakrzewicz A.
        • Hergenreider E.
        • Wilhelm J.
        • Marsh L.M.
        • Sedding D.
        • Klepetko W.
        • Lohmeyer J.
        • Dimmeler S.
        • Seeger W.
        • Weissmann N.
        • Schermuly R.T.
        • Kneidinger N.
        • Eickelberg O.
        • Morty R.E.
        Dysregulation of the IL-13 receptor system: a novel pathomechanism in pulmonary arterial hypertension.
        Am J Respir Crit Care Med. 2010; 182: 805-818
        • van Hinsbergh V.W.
        • Koolwijk P.
        Endothelial sprouting and angiogenesis: matrix metalloproteinases in the lead.
        Cardiovasc Res. 2008; 78: 203-212
        • Holderfield M.T.
        • Hughes C.C.
        Crosstalk between vascular endothelial growth factor, notch, and transforming growth factor-β in vascular morphogenesis.
        Circ Res. 2008; 102: 637-652
        • Merks R.M.
        • Perryn E.D.
        • Shirinifard A.
        • Glazier J.A.
        Contact-inhibited chemotaxis in de novo and sprouting blood-vessel growth.
        PLoS Comput Biol. 2008; 4: e1000163
        • Ochoa C.D.
        • Yu L.
        • Al-Ansari E.
        • Hales C.A.
        • Quinn D.A.
        Thrombospondin-1 null mice are resistant to hypoxia-induced pulmonary hypertension.
        J Cardiothorac Surg. 2010; 5: 32
        • Liu A.
        • Mosher D.F.
        • Murphy-Ullrich J.E.
        • Goldblum S.E.
        The counteradhesive proteins, thrombospondin 1 and SPARC/osteonectin, open the tyrosine phosphorylation-responsive paracellular pathway in pulmonary vascular endothelia.
        Microvasc Res. 2009; 77: 13-20
        • Papaioannou A.I.
        • Zakynthinos E.
        • Kostikas K.
        • Kiropoulos T.
        • Koutsokera A.
        • Ziogas A.
        • Koutroumpas A.
        • Sakkas L.
        • Gourgoulianis K.I.
        • Daniil Z.D.
        Serum VEGF levels are related to the presence of pulmonary arterial hypertension in systemic sclerosis.
        BMC Pulm Med. 2009; 9: 18
        • Kumpers P.
        • Nickel N.
        • Lukasz A.
        • Golpon H.
        • Westerkamp V.
        • Olsson K.M.
        • Jonigk D.
        • Maegel L.
        • Bockmeyer C.L.
        • David S.
        • Hoeper M.M.
        Circulating angiopoietins in idiopathic pulmonary arterial hypertension.
        Eur Heart J. 2010; 31: 2291-2300
        • Ito C.
        • Akimoto T.
        • Ioka T.
        • Kobayashi T.
        • Kusano E.
        TGF-β inhibits vascular sprouting through TGF-β type I receptor in the mouse embryonic aorta.
        Tohoku J Exp Med. 2009; 218: 63-71
        • Jayle C.
        • Favreau F.
        • Zhang K.
        • Doucet C.
        • Goujon J.M.
        • Hebrard W.
        • Carretier M.
        • Eugene M.
        • Mauco G.
        • Tillement J.P.
        • Hauet T.
        Comparison of protective effects of trimetazidine against experimental warm ischemia of different durations: early and long-term effects in a pig kidney model.
        Am J Physiol Renal Physiol. 2007; 292: F1082-F1093
        • Lario S.
        • Bescos M.
        • Campos B.
        • Mur C.
        • Luque P.
        • Alvarez R.
        • Campistol J.M.
        Thrombospondin-1 mRNA expression in experimental kidney transplantation with heart-beating and non-heart-beating donors.
        J Nephrol. 2007; 20: 588-595
        • Pegorier S.
        • Campbell G.A.
        • Kay A.B.
        • Lloyd C.M.
        Bone morphogenetic protein (BMP)-4 and BMP-7 regulate differentially transforming growth factor (TGF)-β1 in normal human lung fibroblasts (NHLF).
        Respir Res. 2010; 11: 85
        • Wang S.
        • de Caestecker M.
        • Kopp J.
        • Mitu G.
        • Lapage J.
        • Hirschberg R.
        Renal bone morphogenetic protein-7 protects against diabetic nephropathy.
        J Am Soc Nephrol. 2006; 17: 2504-2512
        • Reynolds A.M.
        • Xia W.
        • Holmes M.D.
        • Hodge S.J.
        • Danilov S.
        • Curiel D.T.
        • Morrell N.W.
        • Reynolds P.N.
        Bone morphogenetic protein type 2 receptor gene therapy attenuates hypoxic pulmonary hypertension.
        Am J Physiol Lung Cell Mol Physiol. 2007; 292: L1182-L1192
        • Machado R.D.
        • Eickelberg O.
        • Elliott C.G.
        • Geraci M.W.
        • Hanaoka M.
        • Loyd J.E.
        • Newman J.H.
        • Phillips III, J.A.
        • Soubrier F.
        • Trembath R.C.
        • Chung W.K.
        Genetics and genomics of pulmonary arterial hypertension.
        J Am Coll Cardiol. 2009; 54: S32-S42
        • Ricci-Vitiani L.
        • Pallini R.
        • Biffoni M.
        • Todaro M.
        • Invernici G.
        • Cenci T.
        • Maira G.
        • Parati E.A.
        • Stassi G.
        • Larocca L.M.
        • De Maria R.
        Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells.
        Nature. 2010; 468: 824-828
        • Stenmark K.R.
        • Meyrick B.
        • Galie N.
        • Mooi W.J.
        • McMurtry I.F.
        Animal models of pulmonary arterial hypertension: the hope for etiological discovery and pharmacological cure.
        Am J Physiol Lung Cell Mol Physiol. 2009; 297: L1013-L1032